Hualan Biological Engineering
002007.SZ
#3441
Rank
C$5.51 B
Marketcap
C$3.02
Share price
-0.19%
Change (1 day)
-7.64%
Change (1 year)
Hualan Biological Engineering Inc. is a Chinese pharmaceutical company that produces plasma products and vaccines.

Earnings for Hualan Biological Engineering (002007.SZ)

Earnings in 2025 (TTM): C$0.27 Billion

According to Hualan Biological Engineering's latest financial reports the company's current earnings are C$0.63 Billion. In 2024 the company made an earning of C$0.25 Billion a decrease over its 2023 earnings that were of C$0.40 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Hualan Biological Engineering from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$0.27 B5.99%
2024 C$0.25 B-36.03%
2023 C$0.40 B39.14%
2022 C$0.29 B-19.27%
2021 C$0.36 B-17.84%
2020 C$0.43 B37.54%
2019 C$0.31 B11.56%
2018 C$0.28 B50.74%
2017 C$0.18 B1.03%
2016 C$0.18 B23.54%
2015 C$0.15 B8.4%
2014 C$0.14 B10.91%
2013 C$0.12 B54.55%
2012 C$81.92 M-17.1%
2011 C$98.81 M-41.28%
2010 C$0.16 B6.13%
2009 C$0.15 B261.35%
2008 C$43.87 M85.72%
2007 C$23.62 M49.33%
2006 C$15.82 M56.91%
2005 C$10.08 M34.29%
2004 C$7.5 M